{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-inflammatory effect", "antioxidant", "apitheraphy", "heart", "hypertension", "oxidative stress", "rat"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32799699", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "04"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1080/10641963.2020.1806294"], "Journal": {"ISSN": "1525-6006", "JournalIssue": {"Volume": "43", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jan", "Day": "02"}}, "Title": "Clinical and experimental hypertension (New York, N.Y. : 1993)", "ISOAbbreviation": "Clin Exp Hypertens"}, "ArticleTitle": "The investigation of antioxidant and anti-inflammatory potentials of apitherapeutic agents on heart tissues in nitric oxide synthase inhibited rats via N\u03c9-nitro-L-arginine methyl ester.", "Pagination": {"StartPage": "69", "EndPage": "76", "MedlinePgn": "69-76"}, "Abstract": {"AbstractText": ["High blood pressure effects heart and vessels. Development of pathogenesis is the result of oxidative stress. We aimed to investigate the antioxidant effects of propolis, caffeic acid phenethyl ester (CAPE), and pollen on the hearts of rats which chronic nitric oxide synthase (NOS) inhibited through N\u03c9-nitro-L-arginine methyl ester (L-NAME). Paraoxonase 1 (PON1), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), asymmetric dimethylarginine (ADMA), and nuclear factor-\u03baB (NF-\u03baB) were analyzed on the heart.", "Sprague-Dawley rats were divided five groups of seven rats in every group; Group I: Control, Group II: L-NAME, Group III: L-NAME+propolis, Group IV: L-NAME+CAPE and Group V: L-NAME+pollen. L-NAME become dissolved in regular saline (0.9% NaCl w/v). The ethanolic extract of propolis (200 mg/kg/days, gavage), pollen (100 mg/kg/days, by gavage), CAPE (50\u00a0\u00b5M/kg/days, intraperitoneally), and the NOS inhibitor L-NAME (40 mg/kg, intraperitoneally) had been administered.", "Blood pressure (BP) of rats treated with propolis, CAP,E and pollen statistically significant decreased. Decreasing in BP of the rats of pollen group was more than CAPE and propolis groups (<i>P</i> <\u00a0.05). PON1 and TAS levels decreased in L-NAME-treated groups (<i>P</i> <\u00a0.05), but ranges have been better in propolis, CAPE and pollen groups. TOS, ADMA and NF-\u03baB levels increased (<i>P</i> <\u00a0.05) in L-NAME group; however, these parameters were lower (<i>P</i> <\u00a0.05) in propolis and CAPE groups (<i>P</i> <\u00a0.05).", "Vasorelaxant properties and free radical scavenging actions of propolis, CAPE, and pollen may reduce the oxidative stress and blood pressure in the rats chronic NOS inhibited through L-NAME."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, Faculty of Medicine, Nigde \u00d6mer Halisdemir University , Nigde, Turkey."}], "LastName": "Ozdemir", "ForeName": "Betul", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal and Aromatic Plants, Vocational School of Technical Sciences, Aksaray University , Aksaray, Turkey."}], "LastName": "Gulhan", "ForeName": "Mehmet Fuat", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Firat University , Elazig, Turkey."}], "LastName": "Sahna", "ForeName": "Engin", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biology, Faculty of Medicine, Nigde \u00d6mer Halisdemir University, Campus , Nigde, Turkey."}], "LastName": "Selamoglu", "ForeName": "Zeliha", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Clin Exp Hypertens", "NlmUniqueID": "9305929", "ISSNLinking": "1064-1963"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Caffeic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Free Radical Scavengers"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants"}, {"RegistryNumber": "63CV1GEK3Y", "NameOfSubstance": "N,N-dimethylarginine"}, {"RegistryNumber": "9009-62-5", "NameOfSubstance": "Propolis"}, {"RegistryNumber": "94ZLA3W45F", "NameOfSubstance": "Arginine"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase"}, {"RegistryNumber": "EC 3.1.1.2", "NameOfSubstance": "Pon1 protein, rat"}, {"RegistryNumber": "EC 3.1.8.1", "NameOfSubstance": "Aryldialkylphosphatase"}, {"RegistryNumber": "G960R9S5SK", "NameOfSubstance": "caffeic acid phenethyl ester"}, {"RegistryNumber": "ML9LGA7468", "NameOfSubstance": "Phenylethyl Alcohol"}, {"RegistryNumber": "V55S2QJN2X", "NameOfSubstance": "NG-Nitroarginine Methyl Ester"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["analogs & derivatives", "metabolism"], "DescriptorName": "Arginine"}, {"QualifierName": ["metabolism"], "DescriptorName": "Aryldialkylphosphatase"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Caffeic Acids"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Free Radical Scavengers"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["metabolism"], "DescriptorName": "Myocardium"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "NG-Nitroarginine Methyl Ester"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Nitric Oxide Synthase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Oxidants"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Phenylethyl Alcohol"}, {"QualifierName": [], "DescriptorName": "Pollen"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Propolis"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "8", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "18", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32799699", "10.1080/10641963.2020.1806294"]}}]}